Galit Eisenberg

476 total citations
18 papers, 278 citations indexed

About

Galit Eisenberg is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Galit Eisenberg has authored 18 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Galit Eisenberg's work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (10 papers) and CAR-T cell therapy research (9 papers). Galit Eisenberg is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (10 papers) and CAR-T cell therapy research (9 papers). Galit Eisenberg collaborates with scholars based in Israel, United States and Canada. Galit Eisenberg's co-authors include Michal Lotem, Tamar Peretz, Shoshana Frankenburg, Sharon Merims, Arthur Machlenkin, Shiri Klein, Eitan Yefenof, Emma Hajaj, Jacob Pitcovski and Lea Eisenbach and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Galit Eisenberg

16 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galit Eisenberg Israel 12 193 155 90 35 17 18 278
Nela Klein-González Germany 7 243 1.3× 209 1.3× 110 1.2× 19 0.5× 17 1.0× 13 344
Jelle J. Lindenberg Netherlands 11 262 1.4× 185 1.2× 98 1.1× 26 0.7× 10 0.6× 14 373
Ravi K. Dinesh United States 8 168 0.9× 66 0.4× 64 0.7× 27 0.8× 20 1.2× 11 267
Karolina Pilipow Italy 8 244 1.3× 222 1.4× 89 1.0× 38 1.1× 27 1.6× 10 364
Sarah A. E. Galloway United Kingdom 3 158 0.8× 114 0.7× 81 0.9× 31 0.9× 5 0.3× 3 237
Yun-Sun Kim South Korea 7 364 1.9× 216 1.4× 54 0.6× 21 0.6× 8 0.5× 8 415
Alfie T. Baker United Kingdom 8 214 1.1× 118 0.8× 63 0.7× 13 0.4× 11 0.6× 10 302
Hanxi Xiao United States 10 167 0.9× 82 0.5× 109 1.2× 24 0.7× 23 1.4× 19 309
Yuchan Cai China 4 221 1.1× 170 1.1× 72 0.8× 15 0.4× 41 2.4× 6 325
Haven R. Garber United States 9 103 0.5× 162 1.0× 82 0.9× 42 1.2× 28 1.6× 20 245

Countries citing papers authored by Galit Eisenberg

Since Specialization
Citations

This map shows the geographic impact of Galit Eisenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galit Eisenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galit Eisenberg more than expected).

Fields of papers citing papers by Galit Eisenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galit Eisenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galit Eisenberg. The network helps show where Galit Eisenberg may publish in the future.

Co-authorship network of co-authors of Galit Eisenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Galit Eisenberg. A scholar is included among the top collaborators of Galit Eisenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galit Eisenberg. Galit Eisenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stern, Otto, Thomas Eisenhaure, Sarah E. Henrickson, et al.. (2025). Unveiling alternative splicing dynamics in activated T lymphocytes and their implications for immune checkpoint blockade efficacy. iScience. 28(5). 112434–112434.
2.
Stern, Otto, et al.. (2025). Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy. Frontiers in Immunology. 15. 1490035–1490035. 2 indexed citations
3.
Schaft, Niels, Jan Dörrie, Gerold Schuler, et al.. (2023). The future of affordable cancer immunotherapy. Frontiers in Immunology. 14. 1248867–1248867. 38 indexed citations
4.
Weinstein‐Fudim, Liza, Shoshana Frankenburg, Tamar Peretz, et al.. (2023). Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions. Science Translational Medicine. 15(699). eabo0684–eabo0684.
5.
Hajaj, Emma, Sharon Merims, Jonathan Cohen, et al.. (2021). Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions. Cancer Immunology Research. 9(6). 637–650. 14 indexed citations
6.
Hajaj, Emma, Shiri Klein, Sharon Merims, et al.. (2020). Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study. Frontiers in Oncology. 10. 70–70. 30 indexed citations
7.
Hajaj, Emma, Galit Eisenberg, Shiri Klein, et al.. (2020). SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. eLife. 9. 26 indexed citations
8.
Eisenberg, Galit, Emma Hajaj, Sharon Merims, et al.. (2018). Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo. Cancer Immunology Research. 6(2). 127–138. 19 indexed citations
9.
Levin, Noam, Orit Itzhaki, Michal J. Besser, et al.. (2018). Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40. The Journal of Immunology. 201(10). 2959–2968. 12 indexed citations
10.
Levin, Noam, Adi Sharabi‐Nov, Tamar Peretz, et al.. (2018). Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T Cells. Journal of Immunotherapy. 42(2). 43–50. 7 indexed citations
11.
Merims, Sharon, Galit Eisenberg, Jonathan Cohen, et al.. (2016). Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBL. Journal of Immunotherapy. 39(8). 321–328. 9 indexed citations
12.
Levin, Noam, Gal Cafri, Galit Eisenberg, et al.. (2016). Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40. Journal of Immunotherapy. 40(2). 39–50. 10 indexed citations
13.
Eisenberg, Galit, Sharon Merims, Shoshana Frankenburg, et al.. (2015). Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer. PLoS ONE. 10(2). e0118244–e0118244. 11 indexed citations
14.
Eisenberg, Galit, Arthur Machlenkin, Alon Margalit, et al.. (2015). Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells. Clinical & Experimental Immunology. 182(2). 220–229. 15 indexed citations
15.
Eisenberg, Galit, Shoshana Frankenburg, Sharon Merims, et al.. (2013). Imprinting of Lymphocytes with Melanoma Antigens Acquired by Trogocytosis Facilitates Identification of Tumor-Reactive T Cells. The Journal of Immunology. 190(11). 5856–5865. 15 indexed citations
16.
Eisenberg, Galit, Yael Sagi, Shoshana Frankenburg, et al.. (2011). Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones. The Journal of Immunology. 188(2). 632–640. 24 indexed citations
17.
Eisenberg, Galit, Arthur Machlenkin, Shoshana Frankenburg, et al.. (2010). Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response. Cellular Immunology. 266(1). 98–103. 11 indexed citations
18.
Machlenkin, Arthur, Shoshana Frankenburg, Galit Eisenberg, et al.. (2008). Capture of Tumor Cell Membranes by Trogocytosis Facilitates Detection and Isolation of Tumor-Specific Functional CTLs. Cancer Research. 68(6). 2006–2013. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nela Klein-González Breakdown of academic impact, for papers by Jelle J. Lindenberg Breakdown of academic impact, for papers by Ravi K. Dinesh Breakdown of academic impact, for papers by Karolina Pilipow Breakdown of academic impact, for papers by Sarah A. E. Galloway Breakdown of academic impact, for papers by Yun-Sun Kim Breakdown of academic impact, for papers by Alfie T. Baker Breakdown of academic impact, for papers by Hanxi Xiao Breakdown of academic impact, for papers by Yuchan Cai Breakdown of academic impact, for papers by Haven R. Garber
Rankless by CCL
2026